[1] Sharma A, Armstrong AE, Posner MP, et al. Graft-versus-host disease after solid organ transplantation: A single center experience and review of literature. Ann Transplant. 2012; 17(4):133-139.[2] Tait BD, Süsal C, Gebel HM, et al. Consensus Guidelines on the Testing and Clinical Management Issues Associated With HLA and Non-HLA Antibodies in Transplantation. Transplantation. 2013;95(1):19-47.[3] Otten HG, Calis JJ, Ke?mir C, et al. Predicted indirectly recognizable HLA epitopes presented by HLA-DR correlate with the de novo development of donor-specific HLA IgG antibodies after kidney transplantation. Hum Immunol. 2012 Dec 8. [4] Jia BX, Ma WR, Tian Y. Shoudu Yike Daxue Xuebao. 2011; 32(6):838-842.贾保祥,马威然,田野.亲属肾移植患者术后肾功能与HLA配型和PRA相关性研究[J]. 首都医科大学学报,2011,32(6): 838-842.[5] Xu WZ, Jia BX, Yang HJ, et al. Guoji Waikexue Zazhi. 2011; 38(1):25-27.徐婉珍,贾保祥,杨慧静,等.222例活体肾移植供受者HLA分型配合率的分析[J]. 国际外科学杂志,2011,38(1):25-27.[6] Leventhal J, Abecassis M, Miller J, et al. Tolerance Induction in HLA Disparate Living Donor Kidney Transplantation by Donor Stem Cell Infusion: Durable Chimerism Predicts Outcome. Transplantation. 2013;95(1):169-176. [7] Ro H, Min SI, Yang J, et al. Impact of tacrolimus intraindividual variability and CYP3A5 genetic polymorphism on acute rejection in kidney transplantation. Ther Drug Monit. 2012;34(6):680-685.[8] Paramesh A S, Zhang R, Baber J, et al. The effect of HLA mismatch on highly sensitized renal allograft recipients. Clin Transplant. 2010;24(6):E247-E252.[9] Jia BX, Tang YW, Ma WR, et al. Guoji Jianyan Yixue Zazhi. 2011;32(16):1802-1804.贾保祥,唐雅望,马威然,等. HLA配型和PRA对移植肾功能的影响研究[J]. 国际检验医学杂志,2011,32(16):1802-1804.[10] Jia JX, Zhang XD. Guoji Jianyan Yixue Zazhi. 2011; 32(16): 1809-1810, 1813.贾佳熹,张小东.活体亲属肾移植患者HLA配型配合率的分析[J]. 国际检验医学杂志,2011,32(16):1809-1810, 1813.[11] Huang XE,, Li LY, Fan LP, et al. Zhonghua Qiguan Yizhi Zazhi. 2004;25(5):298-301.黄先恩,李留洋,范礼佩,等. 影响致敏患者移植肾存活的危险因素分析[J]. 中华器官移植杂志,2004,25(5):298-301.[12] Li XK, Sun WY, Zhang SX. Haerbin YIke Daxue Xuebao. 2010;44(5):484-488.李兴库,孙文英,张镯潇. 高致敏肾移植患者的HLA等位基因选择性配型的临床意义[J]. 哈尔滨医科大学学报,2010,44(5): 484-488.[13] Zhou YC. Zhonghua Yizhi Zazhi(Dianziban). 2011;5(1): 63-66.周永昌. HLA抗原系统与移植临床[J]. 中华移植杂志(电子版), 2011,5(1):63-66.[14] Wu XD, Yang SJ, Cui YN, et al. Zhongguo Shiyan Zhenduanxue. 2005;5:95-96.吴晓冬,杨绍娟,崔亚南,等. HLA-Ⅰ、Ⅱ类PCR-SSP基因分型与血清学抗原分型在移植配型中的比较应用[J]. 中国实验诊断学, 2005(5):95-96.[15] Zhu JF, Zhang YY, Qi HG. Disi Junyi Daxue Xuebao. 2009; 30(21):2396.朱建锋,张奕奕,祈洪刚. HLA配型与肾移植术后早期排斥反应的关系[J]. 第四军医大学学报,2009,30(21):2396.[16] Ren Y, Yang YR. Xibao yu Fenzi Mianyixue Zazhi. 2007;11: 1080-1082.任雨,杨亦荣. HLA抗体筛选技术的最新进展及其在器官移植中的应用[J]. 细胞与分子免疫学杂志,2007,11:1080-1082.[17] Liang DY, Yue Zj. Guowai Yixue:YIzhi yu Xueye Jinghua Fence. 2005;2:8-11.梁东彦,岳中瑾.再次肾移植[J]. 国外医学:移植与血液净化分册, 2005,2:8-11.[18] Liu XY, Luo M,Xiao LL, et al. Shiyong Yufang Yixue. 2012; 19(8):1125-1127.刘小友,罗敏,肖露露,等. NK受体KIR及其HLA配体对肾移植急性排斥反应的作用[J]. 实用预防医学,2012,19(8): 1125-1127.[19] Han ZM, Xia LL, Yu LX, et al. Xiandai Miniao Waike Zazhi. 2010;15(02):110-113.韩志明,肖露露,于立新,等. 南方汉族等候肾移植终末期肾功能衰竭患者HLA基因多态性分析[J]. 现代泌尿外科杂志, 2010, 15(02):110-113.[20] Jia BX, Ma WY, Tian Y. ZHonghua Weishengwuxue he Mianyixue Zazhi. 2012;32(04):315-317贾保祥,马威然,田野. HLA配型和DSA对移植肾功能的影响研究[J]. 中华微生物学和免疫学杂志,2012,32(04):315-317[21] Xue Wj, Hou J, Tian PX, et al. Zhonghua QIguan Yizhi Zazhi. 2010;31(11):654-656.薛武军,侯军,田普训,等. HLA配型对肾移植长期效果的影响(2508例次总结)[J].中华器官移植杂志,2010,31(11):654-656.[22] Yu LX, Xiao F, Xiao LL, et al. Nanfang Yike Daxue Xuebao. 2010;30(2):288-291.于立新,肖飞,肖露露,等. KIR及其HLA配体与肾移植急性排斥反应的关系[J]. 南方医科大学学报,2010,30(2):288-291.[23] Ling JY. Shanghai Jiaotong Daxue Xuebao:Yixueban. 2006; 26(6):561-562.凌建煜. 同种异体肾移植[J]. 上海交通大学学报:医学版, 2006, 26(6):561-562.[24] Wang CA, Han L. Zhengzhou Daxue Xuebao:Yixueban. 2004; 39(5):872.王长安,韩林. 人异体肾移植HLA配型291例次[J]. 郑州大学学报:医学版,2004,39(5):872.[25] Yang SJ, Xue LJ, Wu XD, et al. Zhongguo Mianyixue Zazhi. 2006;22(9):878-879.杨绍娟,薛丽娟,吴晓冬,等. HLA配型、交叉反应组(CREGs)误配率与肾移植术后早期排斥反应的关系[J]. 中国免疫学杂志, 2006, 22(9):878-879.[26] Jia BX, Ma WR, Tian Y. Zhongguo Weishengwu he Mianyixue Zazhi. 2011;31(2):112.贾保祥,马威然,田野. 活体亲属肾移植患者HLA配型配合率的分析[J]. 中华微生物学和免疫学杂志,2011,31(2):112.[27] Sun XY, XIao LL, Wen N, et al. Guangxi Yike Daxue Xuebao. 2010;27(3):394-396.孙煦勇,肖露露,文宁,等. 氨基酸残基配型策略在高致敏尿毒症患者肾移植中的应用研究[J]. 广西医科大学学报,2010,27(3): 394-396.[28] Chen NY, Zhang W, Wang W, et al. Zhejiang Yixue. 2011; 33(12):1831-1832, 1841.陈男英,章伟,王炜,等. HLA-B新等位基因B*51:02:03的确认和分析[J]. 浙江医学,2011,33(12):1831-1832, 1841.[29] Jiao LX, Yang F, Han Y, et al. Zhongguo Zuzhi Gongcheng Yanjiu. 2012;16(18):3345-3348.焦立新,杨帆,韩瑜,等. 吉林汉族人群HLA-A高分辨基因的多态性分析[J]. 中国组织工程研究,2012,16(18):3345-3348.[30] Wang L, Tian J, Cui XQ, et al. Qiguan Yizhi. 2012;3(1):9-15.王雷,田军,崔先泉,等. 动态监测HLA Ⅰ类分子与降钙素原用于鉴别肾移植术后急性排斥反应与感染的价值[J]. 器官移植, 2012,3(1):9-15.[31] Mao Q, Terasaki P I, Cai J, et al. Analysis of HLA class I specific antibodies in patients with failed allografts. Transplantation. 2007;83(1):54-61.[32] He L, Ji G, DOng GL, et al. Zhonghua Waike Zazhi. 2009;47 (14): 1070-1074.贺梁,季刚,董光龙,等. 主要组织相容性复合体Ⅰ类样分子等位基因与活体小肠、肝、肾移植急性排斥反应相关性研究[J]. 中华外科杂志,2009,47(14):1070-1074.[33] Morath C, Opelz G, Zeier M, et al. Prevention of antibody-mediated kidney transplant rejection. Transpl Int. 2012;25(6):633-645.[34] Li ZF, Zhang S. Xian Jiaotong Daxue Xuebao:Yixueban. 2008; 29(1):1-6.李宗芳,张澍. 脾脏的基础研究进展与展望[J]. 西安交通大学学报:医学版, 2008,29(1):1-6.[35] Bao B, Deili Geersang, Wu WH. Roulei Gongye. 2003;29 (7):20-22.包斌,德里格尔桑,吴文惠. 脾脏及其研究进展[J]. 肉类工业, 2003, 29(7):20-22.[36] Zhang X, Li JP. Zhongguo Shuxue Zazhi. 2005;18(3): 197-199.章旭,李剑平. PCR-SSP在HLA低分辨中判型困难或无法判型的常见原因及解决策略[J]. 中国输血杂志,2005,18(3):197-199.[37] Kanter Berga J, Sancho Calabuig A, Gavela Martinez E, et al. Pretransplant donor-specific HLA antibodies detected by single antigen bead flow cytometry: risk factors and outcomes after kidney transplantation. Transplant Proc. 2012;44(9): 2529-2531.[38] Shao M, Ye Q, Ming Y, et al. Delayed graft function after DCD kidney transplantation: risk factors for and impact on transplantation. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2012;37(10):1045-1049.[39] Ollinger R, Margreiter C, Bösmüller C, et al. Evolution of pancreas transplantation: long-term results and perspectives from a high-volume center. Ann Surg. 2012;256(5):780-787. [40] Nowak I, Magott-Procelewska M, Kowal A, et al. Killer immunoglobulin-like receptor (KIR) and HLA genotypes affect the outcome of allogeneic kidney transplantation. PLoS One. 2012;7(9):e44718. |